Essential Premium

Maverick’s New Top Positions Deliver Both Gains and Setbacks

Tiger Cub Lee Ainslie III added large stakes in Alphabet, Applied Materials, Boston Scientific, and Visa. 

Private Credit Secondaries Surge Amid Muted Exit Environment

A surge in liquidity-driven transactions suggests the asset class may be feeling the strain of prolonged holds and slowing fundraising.

Sponsored

How Ultra 10-Year Futures Became a Treasury Benchmark

Biopharma Hedge Funds Stumble as Last Year’s Rally Fades

Most life sciences and biopharma hedge funds lost money in January after recording one of their best years ever.

Related Content

Now Top Investors Are Doubting the AI Revolution

Michelle Celarier

Tekne Capital’s Beeneet Kothari Plays the Long Game — and Wins Big on China Tech

Michelle Celarier

One of Venture Capital’s Top Firms Just Raised Its Final Fund. Why Is That So Rare?

Julie Segal

1270 Avenue of the Americas, Suite 1100

New York, NY 10020

 

© Institutional Investor, LLC. All material subject to strictly enforced copyright laws. Please read our Terms and Conditions and Privacy Policy before using the site. Institutional Investor is part of Delinian.

 

| Unsubscribe

LinkedIn
X (Twitter)
Bluesky
Instagram